Benralizumab (Fasenra)

From HemOnc.org - A Hematology Oncology Wiki
Revision as of 15:38, 25 July 2019 by Jwarner (talk | contribs) (Created page with "==General information== Class/mechanism: A humanized monoclonal antibody targeting interleukin-5 (IL-5). ==Diseases for which it is used== *Hypereosinophilic syndrome (HES...")
(diff) ← Older revision | Latest revision (diff) | Newer revision → (diff)
Jump to navigation Jump to search

General information

Class/mechanism: A humanized monoclonal antibody targeting interleukin-5 (IL-5).

Diseases for which it is used

History of changes in FDA indication

No approval for hematology/oncology conditions, at this time.

Also known as

  • Brand names: Fasenra
Retrieved from "https://hemonc.org/w/index.php?title=Benralizumab_(Fasenra)&oldid=38940"